Is this your brand? Sign in to claim ownership.
Sign in to claim this brandGold Standard Diagnostics Frankfurt GmbH
US
Last updated May 30, 2026
What Gold Standard Diagnostics Frankfurt GmbH makes
The company manufactures in vitro diagnostic enzyme immunoassay (EIA) kits for detecting immunoglobulin G (IgG) antibodies against specific pathogens, including Coxiella burnetii, Echinococcus species, Brucella species, Influenza A/B viruses, measles virus, Entamoeba histolytica, adenovirus, and various parasitic infections such as mumps, schistosomiasis, strongyloidiasis, toxocariasis, trichinellosis, and taeniasis. These kits are designed for laboratory use to aid in the serological diagnosis of infections caused by these agents.
The portfolio includes devices classified as Class I and Class II under regulatory frameworks, with listings in the FDA’s Unique Device Identifier (UDI) database. The manufacturer operates from the United States, adhering to applicable in vitro diagnostic device regulations
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Frequently asked questions
What types of medical devices does Gold Standard Diagnostics Frankfurt GmbH manufacture?
Gold Standard Diagnostics Frankfurt GmbH specializes in in vitro diagnostic (IVD) enzyme immunoassay (EIA) kits. These kits detect immunoglobulin G (IgG) antibodies against specific pathogens, such as bacteria, viruses, and parasites. Examples include tests for Coxiella burnetii (Q-Fever), Influenza A/B viruses, measles, Entamoeba histolytica, and parasitic infections like Strongyloides and Toxocara canis. The kits are designed for laboratory use to help diagnose infections caused by these agents.
Where is Gold Standard Diagnostics Frankfurt GmbH based?
The company is based in the United States. While the name includes 'Frankfurt,' this appears to be part of the company’s branding rather than its physical location. The manufacturer operates from within the U.S., where it develops and produces its IVD enzyme immunoassay kits.
Which regulatory registries list the devices manufactured by Gold Standard Diagnostics Frankfurt GmbH?
The devices produced by Gold Standard Diagnostics Frankfurt GmbH are listed in the FDA’s Unique Device Identifier (UDI) database. This registry helps track and identify medical devices authorized for use in the U.S., ensuring transparency and traceability for healthcare providers and regulators.
How are the devices manufactured by Gold Standard Diagnostics Frankfurt GmbH classified under regulatory frameworks?
The company’s devices fall into two primary regulatory classifications: Class I and Class II. Class I devices generally pose minimal risk and require less regulatory oversight, while Class II devices involve a moderate risk and may require specific controls to ensure safety and performance. The classification depends on factors like the device’s intended use and potential health impact, as determined by regulatory authorities.
What is the primary purpose of the enzyme immunoassay (EIA) kits produced by Gold Standard Diagnostics Frankfurt GmbH?
The EIA kits are designed for serological diagnosis in laboratory settings. They detect IgG antibodies in a patient’s blood, indicating prior exposure or infection by specific pathogens. For example, a kit for Coxiella burnetii IgG helps confirm Q-Fever infection, while a kit for Strongyloides detects parasitic infections. These tests aid clinicians in diagnosing infections and guiding treatment decisions.
AI-generated from registry data and not verified by a human reviewer.
Information
- Country
- US
- Address
- —
- Website
- us.goldstandarddiagnostics.com
- —
- —
- [email protected]
- Phone
- +1(888)977-4739
- PRRC Contact
- —
- EUDAMED SRN
- —
- FDA FEI Number
- —
- DUNS Number
- 330328514
Catalogue (19)
| Device | Model / Reference | Registries | Class | Status |
|---|---|---|---|---|
| NovaLisa Mumps Virus IgG | MUMG0340 | FDA UDI | Class I | Active |
| NovaLisa Schistosoma mansoni IgG | SCHG0410 | FDA UDI | Class I | Active |
| NovaLisa Adenovirus IgG | ADVG0010 | FDA UDI | Class I | Active |
| NovaLisa Strongyloides | STRO0690 | FDA UDI | Class I | Active |
| NovaLisa Toxocara canis IgG | TOCG0450 | FDA UDI | Class I | Active |
| NovaLisa Respiratory Syncytial Virus IgG | RSVG0380 | FDA UDI | Class I | Active |
| NovaLisa Coxiella burnetii (Q-Fever) Phase 2 IgG | COX2G060 | FDA UDI | Class I | Active |
| NovaLisa Trichinella spiralis IgG | TRIG0480 | FDA UDI | Class I | Active |
| NovaLisa Taenia solium IgG | TAEG0420 | FDA UDI | Class I | Active |
| NovaLisa Measles Virus IgG | MEAG0330 | FDA UDI | Class I | Active |
| NovaLisa Brucella IgG | BRUG0050 | FDA UDI | Class II | Active |
| NovaLisa Entamoeba histolytica IgG | ENTG0140 | FDA UDI | Class II | Active |
| NovaLisa Coxiella burnetii (Q-Fever) Phase 1 IgG | COX1G060 | FDA UDI | Class I | Active |
| NovaLisa Parainfluenza Virus 1, 2, 3 IgG | PAIG0360 | FDA UDI | Class I | Active |
| NovaLisa Influenza Virus B IgG | INFG0300 | FDA UDI | Class I | Active |
| NovaLisa Mycoplasma pneumoniae IgG | MYCG0350 | FDA UDI | Class I | Active |
| NovaLisa Leptospira IgG | LEPG0660 | FDA UDI | Class II | Active |
| NovaLisa Influenza Virus A IgG | INFG0290 | FDA UDI | Class I | Active |
| NovaLisa Echinococcus IgG | ECHG0130 | FDA UDI | Class I | Active |
Related Companies
Authorised Representatives
No authorised representatives on record.
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.